Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2011 | 772 Thousand USD | 6.34% |
| 2010 | 726 Thousand USD | -15.38% |
| 2009 | 858 Thousand USD | -31.85% |
| 2008 | 1.25 Million USD | -32.75% |
| 2007 | 1.87 Million USD | -14.72% |
| 2006 | 2.19 Million USD | -0.27% |
| 2005 | 2.2 Million USD | -28.12% |
| 2004 | 3.06 Million USD | 0.1% |
| 2003 | 3.05 Million USD | -43.01% |
| 2002 | 5.36 Million USD | -32.21% |
| 2001 | 7.91 Million USD | -0.88% |
| 2000 | 7.98 Million USD | 369.94% |
| 1999 | 1.7 Million USD | 30.77% |
| 1998 | 1.3 Million USD | 160.0% |
| 1997 | 500 Thousand USD | 66.67% |
| 1996 | 300 Thousand USD | -40.0% |
| 1995 | 500 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2011 FY | 772 Thousand USD | 6.34% |
| 2010 FY | 726 Thousand USD | -15.38% |
| 2009 Q1 | 153 Thousand USD | -56.66% |
| 2009 FY | 858 Thousand USD | -31.85% |
| 2008 FY | 1.25 Million USD | -32.75% |
| 2008 Q1 | 229 Thousand USD | -66.42% |
| 2008 Q4 | 353 Thousand USD | -23.76% |
| 2008 Q3 | 463 Thousand USD | 117.37% |
| 2008 Q2 | 213 Thousand USD | -6.99% |
| 2007 FY | 1.87 Million USD | -14.72% |
| 2007 Q4 | 682 Thousand USD | 27.72% |
| 2007 Q2 | 260 Thousand USD | -34.51% |
| 2007 Q1 | 397 Thousand USD | -33.28% |
| 2007 Q3 | 534 Thousand USD | 105.38% |
| 2006 Q4 | 595 Thousand USD | 42.34% |
| 2006 Q2 | 718 Thousand USD | 55.08% |
| 2006 FY | 2.19 Million USD | -0.27% |
| 2006 Q1 | 463 Thousand USD | 94.54% |
| 2006 Q3 | 418 Thousand USD | -41.78% |
| 2005 Q4 | 238 Thousand USD | -56.73% |
| 2005 FY | 2.2 Million USD | -28.12% |
| 2005 Q2 | 885 Thousand USD | 67.61% |
| 2005 Q3 | 550 Thousand USD | -37.85% |
| 2005 Q1 | 528 Thousand USD | -31.78% |
| 2004 FY | 3.06 Million USD | 0.1% |
| 2004 Q4 | 774 Thousand USD | -13.9% |
| 2004 Q3 | 899 Thousand USD | 11.54% |
| 2004 Q2 | 806 Thousand USD | 38.25% |
| 2004 Q1 | 583 Thousand USD | -30.1% |
| 2003 Q1 | 727 Thousand USD | -50.68% |
| 2003 FY | 3.05 Million USD | -43.01% |
| 2003 Q4 | 834 Thousand USD | -2.23% |
| 2003 Q3 | 853 Thousand USD | 32.25% |
| 2003 Q2 | 645 Thousand USD | -11.28% |
| 2002 Q2 | 1.27 Million USD | -16.79% |
| 2002 Q3 | 1.07 Million USD | -15.72% |
| 2002 FY | 5.36 Million USD | -32.21% |
| 2002 Q4 | 1.47 Million USD | 36.73% |
| 2002 Q1 | 1.53 Million USD | -46.71% |
| 2001 Q4 | 2.88 Million USD | 60.76% |
| 2001 FY | 7.91 Million USD | -0.88% |
| 2001 Q3 | 1.79 Million USD | 2.81% |
| 2001 Q2 | 1.74 Million USD | 16.64% |
| 2001 Q1 | 1.49 Million USD | -43.99% |
| 2000 Q4 | 2.67 Million USD | 66.63% |
| 2000 FY | 7.98 Million USD | 369.94% |
| 2000 Q1 | 1.08 Million USD | 54.29% |
| 2000 Q2 | 1.69 Million USD | 56.94% |
| 2000 Q3 | 1.6 Million USD | -5.43% |
| 1999 Q1 | 100 Thousand USD | -66.67% |
| 1999 Q4 | 700 Thousand USD | 600.0% |
| 1999 Q2 | 1 Million USD | 900.0% |
| 1999 FY | 1.7 Million USD | 30.77% |
| 1999 Q3 | 100 Thousand USD | -90.0% |
| 1998 FY | 1.3 Million USD | 160.0% |
| 1998 Q4 | 300 Thousand USD | 200.0% |
| 1998 Q3 | 100 Thousand USD | -83.33% |
| 1998 Q2 | 600 Thousand USD | 50.0% |
| 1998 Q1 | 400 Thousand USD | 300.0% |
| 1997 Q1 | 900 Thousand USD | 800.0% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | -50.0% |
| 1997 FY | 500 Thousand USD | 66.67% |
| 1997 Q2 | 200 Thousand USD | -77.78% |
| 1996 Q3 | - USD | -100.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 FY | 300 Thousand USD | -40.0% |
| 1996 Q2 | 200 Thousand USD | 100.0% |
| 1996 Q4 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 100 Thousand USD | 0.0% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1995 FY | 500 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | 75.811% |
| Ansell Limited | 1.61 Billion USD | 99.952% |
| Ansell Limited | 1.61 Billion USD | 99.952% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | 99.582% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -471.619% |
| Psykey, Inc. | 419.29 Thousand USD | -84.117% |
| ConvaTec Group Plc | 2.19 Billion USD | 99.965% |
| ConvaTec Group Plc | 2.14 Billion USD | 99.964% |
| Encision Inc. | 6.58 Million USD | 88.278% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | 57.697% |
| LifePoint, Inc. | -18.5 Thousand USD | 4272.973% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 88.669% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | 21.721% |
| Reflect Scientific, Inc. | 1.08 Million USD | 28.529% |
| SmileDirectClub, Inc. | 470.74 Million USD | 99.836% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.959% |
| SheerVision, Inc. | 3.49 Million USD | 77.939% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | 44.312% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -3.611% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -640.293% |